Hinge Health Inc.
HNGE | NYSE
$94.45
-$0.45 (-0.47%)
At close: Sep 21, 2026, 4:00 PM ET
$94.99
+$0.54 (+0.57%)
Pre-market:
Sep 22, 2026, 8:50 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 |
|---|---|---|---|
Revenue | 587.86M | 390.4M | 292.73M |
Cost of Revenue | 118.56M | 89.81M | 98.55M |
Gross Profit | 469.3M | 300.59M | 194.18M |
Operating Income | -546.37M | -31.91M | -130.51M |
Interest Income | n/a | n/a | n/a |
Pretax Income | -527.26M | -11.26M | -108.55M |
Net Income | -528.26M | -11.93M | -108.14M |
Selling & General & Admin | 639.41M | 227.54M | 214.64M |
Research & Development | 368.14M | 100.84M | 110.06M |
Other Expenses | 8.12M | 4.13M | n/a |
Operating Expenses | 1.02B | 332.5M | 324.69M |
Interest Expense | n/a | n/a | n/a |
Selling & Marketing Expenses | 313.93M | 165.14M | 147.62M |
Cost & Expenses | 1.13B | 422.31M | 423.24M |
Income Tax Expense | 998K | 677K | -405K |
Shares Outstanding (Basic) | 79.19M | 78.02M | 78.02M |
Shares Outstanding (Diluted) | 81.7M | 78.02M | 78.02M |
EPS (Basic) | -5.36 | -0.15 | -1.39 |
EPS (Diluted) | -5.19 | -0.15 | -1.39 |
EBITDA | -535.89M | -22.08M | -128.39M |
EBIT | -541.02M | -24.43M | -130.51M |
Depreciation & Amortization | 5.13M | 2.35M | 2.13M |
Add to Watchlist
Select watchlists to add or remove HNGE